0001104659-19-017816.txt : 20190327 0001104659-19-017816.hdr.sgml : 20190327 20190327154309 ACCESSION NUMBER: 0001104659-19-017816 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190327 DATE AS OF CHANGE: 20190327 EFFECTIVENESS DATE: 20190327 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ContraVir Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001583771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462783806 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-335827 FILM NUMBER: 19708330 BUSINESS ADDRESS: STREET 1: 399 THORNALL STREET STREET 2: FIRST FLOOR CITY: EDISON STATE: NJ ZIP: 08837 BUSINESS PHONE: 732-902-4000 MAIL ADDRESS: STREET 1: 399 THORNALL STREET STREET 2: FIRST FLOOR CITY: EDISON STATE: NJ ZIP: 08837 D 1 primary_doc.xml X0708 D LIVE 0001583771 ContraVir Pharmaceuticals, Inc. 399 Thornall Street 1st Floor Edison NJ NEW JERSEY 08837 732-902-4000 DELAWARE None None Corporation true Robert Foster 399 Thornall Street 1st Floor Edison NJ NEW JERSEY 08837 Executive Officer Director Gary S. Jacob 399 Thornall Street 1st Floor Edison NJ NEW JERSEY 08837 Director John P. Brancaccio 399 Thornall Street 1st Floor Edison NJ NEW JERSEY 08837 Director Thomas Adams 399 Thornall Street 1st Floor Edison NJ NEW JERSEY 08837 Director Timothy Block 399 Thornall Street 1st Floor Edison NJ NEW JERSEY 08837 Director Arnold Lippa 399 Thornall Street 1st Floor Edison NJ NEW JERSEY 08837 Director John Cavan 399 Thornall Street 1st Floor Edison NJ NEW JERSEY 08837 Executive Officer Biotechnology Decline to Disclose 06b false 2019-03-13 false true true false 0 1250000 1250000 0 false 1 0 0 0 false ContraVir Pharmaceuticals, Inc. /s/ John Cavan John Cavan Chief Financial Officer 2019-03-27